全文获取类型
收费全文 | 7482篇 |
免费 | 460篇 |
国内免费 | 54篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 80篇 |
妇产科学 | 109篇 |
基础医学 | 1366篇 |
口腔科学 | 108篇 |
临床医学 | 625篇 |
内科学 | 1680篇 |
皮肤病学 | 98篇 |
神经病学 | 814篇 |
特种医学 | 358篇 |
外科学 | 845篇 |
综合类 | 46篇 |
一般理论 | 8篇 |
预防医学 | 348篇 |
眼科学 | 79篇 |
药学 | 710篇 |
中国医学 | 40篇 |
肿瘤学 | 616篇 |
出版年
2023年 | 37篇 |
2022年 | 196篇 |
2021年 | 267篇 |
2020年 | 140篇 |
2019年 | 159篇 |
2018年 | 201篇 |
2017年 | 136篇 |
2016年 | 169篇 |
2015年 | 205篇 |
2014年 | 273篇 |
2013年 | 353篇 |
2012年 | 567篇 |
2011年 | 610篇 |
2010年 | 315篇 |
2009年 | 288篇 |
2008年 | 492篇 |
2007年 | 596篇 |
2006年 | 535篇 |
2005年 | 504篇 |
2004年 | 456篇 |
2003年 | 435篇 |
2002年 | 385篇 |
2001年 | 58篇 |
2000年 | 30篇 |
1999年 | 60篇 |
1998年 | 79篇 |
1997年 | 57篇 |
1996年 | 51篇 |
1995年 | 46篇 |
1994年 | 20篇 |
1993年 | 39篇 |
1992年 | 20篇 |
1991年 | 13篇 |
1990年 | 13篇 |
1989年 | 7篇 |
1988年 | 5篇 |
1987年 | 8篇 |
1986年 | 15篇 |
1984年 | 10篇 |
1983年 | 16篇 |
1982年 | 13篇 |
1981年 | 9篇 |
1980年 | 10篇 |
1979年 | 8篇 |
1978年 | 10篇 |
1977年 | 11篇 |
1976年 | 7篇 |
1975年 | 9篇 |
1974年 | 6篇 |
1921年 | 5篇 |
排序方式: 共有7996条查询结果,搜索用时 15 毫秒
71.
van Karnebeek Clara D. Blydt-Hansen Ingrid Matthews Allison M. Avramovic Vladimir Price Magda Drogemoller Britt Shyr Casper Lee Jessica Mwenifumbo Jill Ghani Aisha Stockler Sylvia Friedman Jan M. Lehman Anna Ross Colin J. Wasserman Wyeth W. Tarailo-Graovac Maja Horvath Gabriella A. 《Neurogenetics》2021,22(4):251-262
neurogenetics - Monoamine neurotransmitter disorders present predominantly with neurologic features, including dystonic or dyskinetic cerebral palsy and movement disorders. Genetic conditions that... 相似文献
72.
The Personal Development Study (PDS) was administered to four diagnostic groups, which included 89 hospitalized alcoholics, 336 unmarried mothers, 159 college students, and 387 chronic institutionalized schizophrenics. The PDS data from the four groups were factor analyzed separately by Varimax rotation of principal component factors. Cluster analysis methods were used to compare the separate diagnostic group factors with the overall factors previously reported by Pishkin and Thorne (1977). Only a few close fits of the diagnostic group factors showed large differences in item composition, order of emergence of factors and size of loadings between groups. Because many items and factors could be interpreted in terms of several alternative theoretical systems, interpretations were based on the clinical meanings of items and clusters in terms of integration theory (Thorne, 1976). 相似文献
73.
Andrew I. Mikhail Peter L. Nagy Katherine Manta Nicholas Rouse Alexander Manta Sean Y. Ng Michael F. Nagy Paul Smith Jian-Qiang Lu Joshua P. Nederveen Vladimir Ljubicic Mark A. Tarnopolsky 《The Journal of clinical investigation》2022,132(10)
BackgroundMyotonic dystrophy type 1 (DM1) is a complex life-limiting neuromuscular disorder characterized by severe skeletal muscle atrophy, weakness, and cardiorespiratory defects. Exercised DM1 mice exhibit numerous physiological benefits that are underpinned by reduced CUG foci and improved alternative splicing. However, the efficacy of physical activity in patients is unknown.MethodsEleven genetically diagnosed DM1 patients were recruited to examine the extent to which 12 weeks of cycling can recuperate clinical and physiological metrics. Furthermore, we studied the underlying molecular mechanisms through which exercise elicits benefits in skeletal muscle of DM1 patients.RESULTSDM1 was associated with impaired muscle function, fitness, and lung capacity. Cycling evoked several clinical, physical, and metabolic advantages in DM1 patients. We highlight that exercise-induced molecular and cellular alterations in patients do not conform with previously published data in murine models and propose a significant role of mitochondrial function in DM1 pathology. Finally, we discovered a subset of small nucleolar RNAs (snoRNAs) that correlated to indicators of disease severity.ConclusionWith no available cures, our data support the efficacy of exercise as a primary intervention to partially mitigate the clinical progression of DM1. Additionally, we provide evidence for the involvement of snoRNAs and other noncoding RNAs in DM1 pathophysiology.Trial registrationThis trial was approved by the HiREB committee (no. 7901) and registered under ClinicalTrials.gov ().FundingNeil and Leanne Petroff. Canadian Institutes of Health Research Foundation (no. 143325). NCT04187482相似文献
74.
Michael Nazarkovsky Albina Mikhraliieva Carlos A. Achete Luiz Anastacio Alves Joyce Araujo Brulio S. Archanjo Jos Júnior Frana de Barros Liana Monteiro da Fonseca Cardoso Jos Nelson S. S. Couceiro Fernanda Davi Marques Bruno S. Oliveira Rafael Nascimento Dias de Souza Ayla Josma Teixeira Thiago L. Vasconcelos Vladimir Zaitsev 《RSC advances》2022,12(23):14342
Rational synthesis and simple methodology for the purification of large (35–45 nm in lateral size) and flat (1.0–1.5 nm of height) nitrogen-doped graphene oxide quantum dots (GOQDs) are presented. The methodology allows robust metal-free and acid-free preparation of N-GOQDs with a yield of about 100% and includes hydrothermal treatment of graphene oxide with hydrogen peroxide and ammonia. It was demonstrated that macroscopic impurities can be separated from N-GOQD suspension by their coagulation with 0.9% NaCl solution. Redispersible in water and saline solutions, particles of N-GOQDs were characterized using tip-enhanced Raman spectroscopy (TERS), photoluminescent, XPS, and UV-VIS spectroscopies. The size and morphology of N-GOQDs were studied by dynamic light scattering, AFM, SEM, and TEM. The procedure proposed allows nitrogen-doped GOQDs to be obtained, having 60–51% of carbon, 34–45% of oxygen, and up to 7.2% of nitrogen. The N-GOQD particles obtained in two hours of synthesis contain only pyrrolic defects of the graphene core. The fraction of pyridine moieties grows with the time of synthesis, while the fraction of quaternary nitrogen declines. Application of TERS allows demonstration that the N-GOQDs consist of a graphene core with an average crystallite size of 9 nm and an average distance between nearest defects smaller than 3 nm. The cytotoxicity tests reveal high viability of the monkey epithelial kidney cells Vero in the presence of N-GOQDs in a concentration below 60 mg L−1. The N-GOQDs demonstrate green luminescence with an emission maximum at 505 nm and sedimentation stability in the cell culture medium.This paper reveals the methodology for robust preparation of purified nitrogen-doped graphene oxide quantum dots with non-cytotoxic activity against monkey epithelial kidney cells (Vero ATCC® CCL-81™). 相似文献
75.
Ljiljana Vlaški Dragan Dankuc Nada Vučković Vladimir Kljajić Danijela Dragičević Slobodanka Lemajić-Komazec 《Central European Journal of Medicine》2012,7(3):344-348
Aim
The aim of this paper is to present two case reports of patients with hemangiomas of the external auditory canal, and to overview all cases published in English language literature so far. 相似文献76.
77.
Anton R. Kiselev M.D. D.Sc. Vladimir I. Gridnev M.D. D.Sc. Mikhail D. Prokhorov D.Sc. Anatoly S. Karavaev Ph.D. Olga M. Posnenkova M.D. Ph.D. Vladimir I. Ponomarenko D.Sc. Boris P. Bezruchko D.Sc. Vladimir A. Shvartz M.D. Ph.D. 《Annals of noninvasive electrocardiology》2012,17(3):204-213
Background: Synchronization between 0.1‐Hz rhythms in cardiovascular system is deteriorated at acute myocardial infarction (AMI) leading to a disruption of natural functional couplings within the system of autonomic regulation. Objective: This study evaluates the prognostic value of autonomic regulation indices for the 5‐year risk of fatal and nonfatal cardiovascular events in patients after AMI. Methods and Results: We studied 125 patients (53 [42%] female) after AMI aged between 30 and 83 years. The period of observation was 5 years with checkpoints at the first week after AMI and after each year after AMI. We compared the prognostic value of established clinical characteristics and degree S of synchronization between 0.1‐Hz rhythms in heart rate and microcirculation for evaluation of the 5‐year risk of mortality and recurrent myocardial infarction (MI) in patients after AMI. Acute heart failure Killip 2–4 at AMI and S < 20% at the first week after AMI were identified as the most important factors for evaluation of the risk of 5‐year mortality in patients after AMI (χ2= 14.2, P = 0.003). Sensitivity and specificity of low S (<20%) at the first week after AMI were 76% and 43%, respectively. For evaluation of the 5‐year risk of recurrent MI index S had no advantage over established clinical characteristics. Conclusion: The value of S below 20% in patients with AMI is a sensitive marker of high risk of mortality during the subsequent five years. It is characterized by better prognostic value than most of established clinical characteristics. 相似文献
78.
Vladimir Carli Peter Parzer Camilla Wasserman Birgitta Floderus Alan Apter Judit Balazs Shira Barzilay Julio Bobes Romuald Brunner Paul Corcoran Doina Cosman Padraig Cotter Romain Despalins Nadja Graber Francis Guillemin Christian Haring Jean‐Pierre Kahn Laura Mandelli Dragan Marusic Gergely Mészáros George J. Musa Vita Postuvan Franz Resch Pilar A. Saiz Merike Sisask Airi Varnik Marco Sarchiapone Christina W. Hoven Danuta Wasserman 《Addiction (Abingdon, England)》2012,107(12):2210-2222
79.
Grzegorz Kacprzak Andrzej Majewski Jerzy Kolodziej Adam Rzechonek Robert Gürlich Vladimir Bobek 《The Brazilian journal of infectious diseases》2013,17(1):90-93
Empyema is a severe complication of different diseases and traumas. Management of this complication is difficult and should comprise general and local procedures. The general procedure is mainly based on administering wide-spectrum antibiotics. Local management depends on patient general condition, but in all cases the essential procedure is to insert a drain into the pleural cavity and to evacuate the pus. Sometimes pus is very thick and its evacuation and following re-expansion of the lung is rather impossible. In these patients surgical intervention is needed. The use of intrapleural enzymes to support the drainage was first described in 1949 by Tillett and Sherry using a mixture of streptokinase and streptococcal deoxyribonuclease. Nowadays, purified streptokinase has come into widespread use, but recent studies reported no streptokinase effect on pus viscosity. On the other side, deoxyribonuclease reduces pus viscosity and may be more useful in treatment. We report two cases of intrapleural administration of Pulmozyme (alfa dornase – deoxyribonuclease (HOFFMANN-LA ROCHE AG) in dosage 2 × 2.5 mg with a significant improvement caused by changes in pus viscosity. 相似文献
80.
Jan-Peter van Wieringen Jan Booij Vladimir Shalgunov Philip Elsinga Martin C. Michel 《Naunyn-Schmiedeberg's archives of pharmacology》2013,386(2):135-154
Dopamine D2 receptors, similar to other G-protein-coupled receptors, exist in a high- and low-affinity state for agonists. Based upon a review of the methods for detecting D2 receptor agonist high-affinity states, we discuss alterations of such states in animal models of disease and the implications of such alterations for their labelling with positron emission tomography (PET) and single-photon emission computed tomography (SPECT) tracers. The classic approach of detecting agonist high-affinity states compares agonist competition for antagonist radioligands, in most cases using [3H]-spiperone as the radioligand; alternative approaches and radioligands have been proposed, but their claimed advantages have not been substantiated by other investigators. In view of the advantages and disadvantages of various techniques, we critically have reviewed reported findings on the detection of D2 receptor agonist high-affinity states in a variety of animal models. These data are compared to the less numerous findings from human in vivo studies based on PET and SPECT tracers; they are interpreted in light of the finding that D2 receptor agonist high-affinity states under control conditions may differ between rodent and human brain. The potential advantages of agonist ligands in studies of pathophysiology and as diagnostics are being discussed. 相似文献